Ahmed M. Soliman

4.6k total citations · 1 hit paper
142 papers, 2.9k citations indexed

About

Ahmed M. Soliman is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Immunology. According to data from OpenAlex, Ahmed M. Soliman has authored 142 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Reproductive Medicine, 57 papers in Obstetrics and Gynecology and 40 papers in Immunology. Recurrent topics in Ahmed M. Soliman's work include Endometriosis Research and Treatment (77 papers), Uterine Myomas and Treatments (54 papers) and Psoriasis: Treatment and Pathogenesis (36 papers). Ahmed M. Soliman is often cited by papers focused on Endometriosis Research and Treatment (77 papers), Uterine Myomas and Treatments (54 papers) and Psoriasis: Treatment and Pathogenesis (36 papers). Ahmed M. Soliman collaborates with scholars based in United States, Canada and Germany. Ahmed M. Soliman's co-authors include Mahesh Fuldeore, Eric S. Surrey, Michael C. Snabes, Jane Castelli‐Haley, Hongbo Yang, Ella X. Du, Craig A. Winkel, Karin S. Coyne, Sanjay K. Agarwal and Machaon Bonafede and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ahmed M. Soliman

129 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of Endometriosis on Life-Course Potential: A Narrative Review

2021 123 citations Stacey A. Missmer, Frank F. Tu et al. International Journal of General Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ahmed M. Soliman United States	29	2.1k	1.6k	741	570	305	142	2.9k
Maria Elisabetta Coccia Italy	28	1.9k 0.9×	1.3k 0.8×	423 0.6×	623 1.1×	72 0.2×	108	2.6k
Erica E. Marsh United States	33	2.4k 1.2×	2.0k 1.3×	427 0.6×	484 0.8×	53 0.2×	146	3.4k
Wendy Wolfman Canada	22	1.2k 0.6×	992 0.6×	100 0.1×	393 0.7×	99 0.3×	68	2.4k
Idhaliz Flores Puerto Rico	26	1.5k 0.7×	981 0.6×	683 0.9×	433 0.8×	39 0.1×	76	2.0k
Carlos Calhaz–Jorge Portugal	23	2.7k 1.3×	1.6k 1.0×	522 0.7×	847 1.5×	59 0.2×	56	3.2k
FM Helmerhorst Netherlands	24	596 0.3×	224 0.1×	199 0.3×	624 1.1×	71 0.2×	41	1.9k
Francisco José Cândido dos Reis Brazil	23	832 0.4×	562 0.4×	157 0.2×	520 0.9×	191 0.6×	150	1.9k
Suzanne G. Folger United States	30	852 0.4×	458 0.3×	105 0.1×	1.3k 2.2×	26 0.1×	60	3.3k
R. Felberbaum Germany	24	2.0k 1.0×	274 0.2×	246 0.3×	1.6k 2.7×	20 0.1×	126	2.8k
Mette Haase Moen Norway	24	1.3k 0.7×	984 0.6×	450 0.6×	378 0.7×	70 0.2×	65	2.2k

Countries citing papers authored by Ahmed M. Soliman

Since Specialization

Citations

This map shows the geographic impact of Ahmed M. Soliman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed M. Soliman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed M. Soliman more than expected).

Fields of papers citing papers by Ahmed M. Soliman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed M. Soliman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed M. Soliman. The network helps show where Ahmed M. Soliman may publish in the future.

Co-authorship network of co-authors of Ahmed M. Soliman

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed M. Soliman. A scholar is included among the top collaborators of Ahmed M. Soliman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed M. Soliman. Ahmed M. Soliman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thaçi, Diamant, Mamitaro Ohtsuki, Julia‐Tatjana Maul, et al.. (2025). Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months. Dermatology and Therapy. 15(2). 381–394. 5 indexed citations

Östör, Andrew J.K., Filip Van den Bosch, Kim Papp, et al.. (2024). Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial. Rheumatology and Therapy. 11(3). 633–648. 9 indexed citations

Cestari, Tânia Ferreira, Cacilda da Silva Souza, Luna Azulay‐Abulafia, et al.. (2024). Efficacy and safety of risankizumab versus methotrexate in patients with moderate-to-severe plaque psoriasis: results from IMMbrace, a randomized, double-blind, phase 3 study with an open-label extension period in Brazil. Anais Brasileiros de Dermatologia. 100(2). 260–271.

Miller, Charles E., Jin Hee Kim, Robin Kroll, et al.. (2024). Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: twelve months of an ongoing randomized phase 3 trial. American Journal of Obstetrics and Gynecology. 231(6). 630.e1–630.e13. 9 indexed citations

Rosmarin, David, et al.. (2024). Health-Related Quality of Life Burden Among Adults with Vitiligo: Relationship to Disease Severity and Disease Location. Dermatology and Therapy. 14(6). 1633–1647. 6 indexed citations

Jackson, Christopher, Ahmed M. Soliman, Anthony K.C. Chan, et al.. (2024). Patient Experiences of Using Wearable Health Monitors During Cancer Treatment: A Qualitative Study. Clinical Oncology. 37. 103664–103664.

Passeron, Thierry, Khaled Ezzedine, Iltefat Hamzavi, et al.. (2024). Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study. EClinicalMedicine. 73. 102655–102655. 16 indexed citations

Östör, Andrew J.K., Filip Van den Bosch, Kim Papp, et al.. (2024). Long-Term Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results From the KEEPsAKE 2 Trial. SKIN The Journal of Cutaneous Medicine. 8(6). s446–s446.

Behrens, Frank, Mauro Waldemar Keiserman, Kim Papp, et al.. (2024). Long-Term Efficacy and Safety of Risankizumab for csDMARD-IR Patients With Active Psoriatic Arthritis: 196-Week Results From the KEEPsAKE 1 Trial. SKIN The Journal of Cutaneous Medicine. 8(6). s445–s445.

10.

Ezzedine, Khaled, et al.. (2023). Comorbidity Burden Among Patients with Vitiligo in the United States: A Large-Scale Retrospective Claims Database Analysis. Dermatology and Therapy. 13(10). 2265–2277. 16 indexed citations

11.

Tada, Yayoi, Ahmed M. Soliman, L. Puig, et al.. (2023). Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan. Dermatology and Therapy. 14(1). 99–114. 6 indexed citations

12.

Missmer, Stacey A., Frank F. Tu, Ahmed M. Soliman, et al.. (2022). Impact of endometriosis on women’s life decisions and goal attainment: a cross-sectional survey of members of an online patient community. BMJ Open. 12(4). e052765–e052765. 19 indexed citations

13.

Missmer, Stacey A., Frank F. Tu, Sanjay K. Agarwal, et al.. (2021). Impact of Endometriosis on Life-Course Potential: A Narrative Review. International Journal of General Medicine. Volume 14. 9–25. 123 indexed citations breakdown →

14.

Blauvelt, Andrew, Kenneth B. Gordon, Patricia Lee, et al.. (2021). Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis. Journal of Dermatological Treatment. 33(4). 2085–2093. 12 indexed citations

15.

Agarwal, Sanjay K., Ahmed M. Soliman, Julia C. Bond, & Andrew J. Epstein. (2019). National Patterns of Emergency Department Use for Women with Endometriosis, 2006–2015. Journal of Women s Health. 29(3). 420–426. 4 indexed citations

16.

Wyrwich, Kathleen W., Christopher O’Brien, Ahmed M. Soliman, & Kristof Chwalisż. (2018). Development and Validation of the Endometriosis Daily Pain Impact Diary Items to Assess Dysmenorrhea and Nonmenstrual Pelvic Pain. Reproductive Sciences. 25(11). 1567–1576. 19 indexed citations

17.

Davis, Matthew, Ahmed M. Soliman, Jane Castelli‐Haley, Michael C. Snabes, & Eric S. Surrey. (2018). Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids. Journal of Women s Health. 27(10). 1204–1214. 42 indexed citations

18.

Carr, Bruce R., Elizabeth A. Stewart, David F. Archer, et al.. (2018). Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas. Obstetrics and Gynecology. 132(5). 1252–1264. 54 indexed citations

19.

Soliman, Ahmed M., et al.. (2017). Retreatment Rates Among Endometriosis Patients Undergoing Hysterectomy or Laparoscopy. Journal of Women s Health. 26(6). 644–654. 21 indexed citations

20.

Cordero‐Reyes, Andrea M., Keith A. Youker, Ahmed M. Soliman, et al.. (2014). Abstract 19229: IL-18 a Powerful Activator of B-cells is Associated With Mortality in Acute Decompensated Heart Failure. Circulation. 130. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact